The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most critical vaccine-related issues and drive impactful change. It was launched in 2018 as a joint initiative between Sabin and the Aspen Institute.
Members are influential, creative, out-of-the-box thinkers from the scientific, business, global health and philanthropic fields. Each year, they vigorously probe a single challenge in vaccine development and delivery. They then produce actionable recommendations improving how vaccines are made, distributed and used — as well as evidence-based and cost-effective approaches to immunization.
Sabin-Aspen Vaccine Science & Policy Group Reports
Explore the Groups’ “Big Ideas” tackling pressing challenges in vaccine research and development, access and acceptance:
![Vial being filled by a syringe](/app/uploads/2022/05/Sabin-Aspen-RandD_Page_009-aspect-ratio-990-715.jpg)
![Sabin-Aspen Report Cover](/app/uploads/2022/04/Sabin-Aspen-General-Graphic-IG-aspect-ratio-990-715-1.jpg)
Meeting the Challenge of Vaccination Hesitancy
![](/app/uploads/2022/05/Sabin-Aspen-Logo-Square-aspect-ratio-990-715.jpg)